A Novel Endoscopic Attachment Cap for Benign Esophageal Stricture Dilation in Children: a Randomized, Multicentric Pilot Study
Led by University Children's Hospital, Zurich · Updated on 2024-12-11
40
Participants Needed
3
Research Sites
N/A
Total Duration
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
How is the study designed?
Frequently Asked Questions
Research Publications
AI-Summary
What this Trial Is About
This research aims to evaluate the safety and effectiveness of the BougieCap device for stretching narrow areas in the esophagus (food pipe) in children. The study compares the BougieCap with traditional dilation methods such as Savary-Bougie or balloon dilation. The goal is to determine if the BougieCap works better, is easier to use, and causes fewer problems or discomfort for children with benign esophageal strictures.
Participants are randomly assigned to one of two groups: one group using the BougieCap attached to an endoscope that allows direct visual and tactile control during dilation, and the other group receiving standard treatment with either Savary-Bougie dilation or balloon dilation under endoscopic or radiological control. These treatments involve gradually widening the narrow esophageal areas using different techniques and sizes of dilators or balloons.
During the study, participants will answer questions about their symptoms before treatment, 24 hours after, and 14 days later, either during regular hospital visits or over the phone. Researchers will monitor the success of the dilation immediately after the procedure and assess any adverse events, such as bleeding or infections. The study does not add extra risks or burdens for participants and continues until December 2026.
CONDITIONS
Brief Title
An Innovative Endoscopic Cap for Dilating Benign Esophageal Strictures in Children
Who Can Participate
Age: 0Years - 18Years
All Genders
Eligibility Criteria
You may qualify if you...
Age under 18 years
Indication for endoscopic esophageal dilation
Benign stenosis
Written Informed Consent signed by the subject and/or parent/legal representative (if applicable)
You will not qualify if you...
Stenosis that cannot be treated endoscopically
Malignant esophageal strictures
Contraindications and limitations of the medical device as described in the instructions for use
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - Single session for dilation procedure
Participants undergo esophageal dilation using either the BougieCap device or one of the standard dilation techniques, Savary-Bougie or balloon dilation, under endoscopic or radiological control.
1 treatment visit (in-person)
Trial Site Locations
Total: 3 locations
1
Maternal and Child Health Department, University Hospital - Umberto I Sapienza - University of Rome,
Rome, Italy, 00161
Actively Recruiting
2
University Children's Hospital Zurich
Zurich, Canton of Zurich, Switzerland, 8032
Actively Recruiting
3
Universitäts-Kinderspital beider Basel
Basel, Switzerland, 4056
Actively Recruiting
Loading map...
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Technical feasibility, clinical effectiveness, and safety of esophageal stricture dilation using a novel endoscopic attachment cap in adults with eosinophilic esophagitis.
Alain M Schoepfer, Sarah Henchoz, Luc Biedermann...